Employee Login
Logo Thing main logo
Logo Thing main logo

Publication 2021

Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.

Mandal S, Arinaminpathy N, Bhargava B, Panda S
Indian J Med Res. 2021 Jul 2

Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052.

Chagomerana MB, Hosseinipour MC, Pilotto JH, Badal-Faesen S, Nyirenda M, Shava E, Godbole SV, Akelo V, Chariyalertsak S, Panchia R, Cohen M
Int J STD AIDS. 2021 Jul 7:9564624211030368

Emerging Technologies for In Vitro Inhalation Toxicology

Singh AV, Romeo A, Scott K, Wagener S, Leibrock L, Laux P, Luch A, Kerkar P, Balakrishnan S, Dakua SP, Park BW.
Adv Healthc Mater. 2021 Jul 22:e2100633.

Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.

Yadav PD, Sapkal GN, Ella R, Sahay RR, Nyayanit DA, Patil DY, Deshpande G, Shete AM, Gupta N, Mohan VK, Abraham P, Panda S, Bhargava B
J Travel Med. 2021 Jul 6:taab104

Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees.

Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Sahay RR, Shete AM, Panda S, Bhargava B, Mohan VK
Clin Infect Dis. 2021 May 7:ciab411.

Microbiota and cancer: current understanding and mechanistic implications.

Khan AA, Sirsat AT, Singh H, Cash P.
Clin Transl Oncol. 2021 Aug 13

Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings

Shete A, Dhayarkar S, Dhamanage A, Kulkarni S, Ghate M, Sangle S, Medhe U, Verma V, Rajan S, Hattori T, Gangakhedkar R
AIDS Res Ther. 2020 Jul 16;17(1):1-9.

Orientia tsutsugamushi: The dangerous yet neglected foe from the East

Banerjee A, Kulkarni S.
Int J Med Microbiol. 2021 Jan; 311(1):151467.

Bacterial nucleomodulins and cancer: An unresolved enigma.

Khan AA, Khan Z.
Transl Oncol. 2021 Jan;14(1):100922.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy.

Klionsky DJ, et al. Among authors: Mukherjee A
2021 Jan;17(1):1-382.

ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.

Singh H, Choudhari R, Nema V, Khan AA.
Microb Pathog. 2021 Jan;150:104121.

Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates

Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, Panda S, Bhargava B
Indian J Med Res. 2021 Jan & Feb;153(1 & 2):93-114.

Face mask - An essential armour in the fight of India against COVID-19.

Panda S, Kaur H, Dandona L, Bhargava B
Indian J Med Res. 2021 Jan & Feb;153(1-2):233-237.

A Pilot Study of the effects of Yoga Prana Vidya (YPV) protocols on social behaviour, cognitive abilities and IQ of mentally challenged children.

Khatri R, Bembalkar S, Nanduri VS
Pediatr Rev Int J Pediatr Res 2021 Jan-Feb; 8(1):7-15.

A Couples-Based Intervention (Ghya Bharari Ekatra) for the Primary Prevention of Intimate Partner Violence in India: Pilot Feasibility and Acceptability Study.

Kalokhe AS, Iyer S, Gadhe K, Katendra T, Kolhe A, Rahane G, Stephenson R, Sahay S.
JMIR Form Res. 2021 Feb 1;5(2): e26130.

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model.

Mohandas S, Yadav PD, Shete-Aich A, Abraham P, Vadrevu KM, Sapkal G, Mote C, Nyayanit D, Gupta N, Srinivas VK, Kadam M, Kumar A, Majumdar T, Jain R, Deshpande G, Patil S, Sarkale P, Patil D, Ella R, Prasad SD, Sharma S, Ella KM, Panda S, Bhargava B
iScience. 2021 Feb 19;24(2):102054.

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S
N Engl J Med. 2021 Feb 11;384(6):497-511.

Modulating catalytic activity of human topoisomerase II α enzyme by fluorescent gold nanoclusters. Int J Biol Macromol

Dubey A, Singh V, Doharey PK, Sk MP, Samanta SK, Nema V, Sharma B, Varadwaj PK, Sahoo AK.
2021 Feb 15;170: 523-531.

Rotavirus Induces Epithelial-Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b.

Mukhopadhyay U, Banerjee A, Chawla-Sarkar M, Mukherjee A
Front Microbiol. 2021 Feb 18;12:631183.

Portable and sensitive Ag nanorods based SERS platform for rapid HIV-1 detection and tropism determination.

Yadav S, Senapati S, Desai D, Gahlaut S, Kulkarni S, Singh JP.
Colloids Surf B Biointerfaces. 2021 Feb;198:111477.

Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.

Khan AA, Khan Z.
Brief Bioinform. 2021 Mar 22; 22(2):1206-1214.

Current status of probiotics for prevention and management of gastrointestinal cancers.

Khan AA, Nema V, Khan Z.
Expert Opin Biol Ther. 2021 Mar; 21(3):413-422.

SARS-CoV-2 re-infection: development of an epidemiological definition from India.

Mukherjee A, Anand T, Agarwal A, Singh H, Chatterjee P, Narayan J, Rana S, Gupta N, Bhargava B, Panda S.
Epidemiol Infect. 2021 Mar 26:149:e82.

ICMR Serosurveillance Group. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.

Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, Kumar MS, Rade K, Sabarinathan R, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Khan SMS, Kumar CPG, Kumar MS, Laxmaiah A, Madhukar M, Mahapatra A, Mohanty SS, Rangaraju C, Turuk A, Baradwaj DK, Chahal AS, Debnath F, Haq I, Kalliath A, Kanungo S, Kshatri JS, Lakshmi GGJN, Mitra A, Nirmala AR, Prasad GV, Qurieshi MA, Sahay S, Sangwan RK, Sekar K, Shukla VK, Singh PK, Singh P, Singh R, Varma DS, Viramgami A, Panda S, Reddy DCS, Bhargava B;
Lancet Glob Health. 2021 Mar; 9(3):e257-e266.

Investigations of seasonal outbreaks of acute encephalitis syndrome due to Orientia tsutsugamushi in Gorakhpur region, India: A One Health case study.

Murhekar MV, Vivian Thangaraj JW, Sadanandane C, Mittal M, Gupta N, Rose W, Sahay S, Kant R, Gupte MD
Indian J Med Res. 2021 Mar;153(3):375-381.

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques

Yadav PD, Ella R, Kumar S, Patil DR, Mohandas S, Shete AM, Vadrevu KM, Bhati G, Sapkal G, Kaushal H, Patil S, Jain R, Deshpande G, Gupta N, Agarwal K, Gokhale M, Mathapati B, Metkari S, Mote C, Nyayanit D, Patil DY, Sai Prasad BS, Suryawanshi A, Kadam M, Kumar A, Daigude S, Gopale S, Majumdar T, Mali D, Sarkale P, Baradkar S, Gawande P, Joshi Y, Fulari S, Dighe H, Sharma S, Gunjikar R, Kumar A, Kalele K, Srinivas VK, Gangakhedkar RR, Ella KM, Abraham P, Panda S, Bhargava B
Nat Commun. 2021 Mar 2;12(1):1386.

One World One Health: Widening horizons.

Panda S, Bhargava B, Gupte MD
Indian J Med Res. 2021 Mar;153(3):241-243.

Agreement between dried blood spots and HemoCue in Tamil Nadu, India.

Roshania RP, Mehta RV, Shete A, Bingewar R, Kulkarni S, Mahajan A, Miller G, Tarozzi A, Martorell R.
Sci Rep. 2021 Apr 29;11(1): 9285.

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.

Suryawanshi P, Bagul R, Shete A, Thakar M.
Front Immunol. 2021 Apr 30;12: 663919.

Role of Host Genetic Factors in Patients with Astrocytomas.

Singh H, Choudhari R
J Biotechnol Biomater. 2021. Apr-Jun; 11(2):2.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.

Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S
Lancet Infect Dis. 2021 May; 21: 637-646.

Knowledge, attitude and practices towards COVID-19 among people living with HIV in Pune, India: a cross-sectional study.

Ghate MV, Shidhaye PR, Gadhe KR, Gurav SG, Deoraj P.
Int J Res Med Sci. 2021 May;9(5):1458-1465.

Reference Ranges of Different Lymphocyte Subsets in Indian Children: A Multi-Centric Study.

Thakar M, Saxena V, Janakiram N, Ravi V, Desai A, Singh S, Shivanna N, Minz RY, Singh A, Chatterjee M, Madkaikar M.
Indian Pediatr. 2021 May 1;58(5):424-9.

Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities.

Mullick R, Sutar J, Hingankar N, Deshpande S, Thakar M, Sahay S, Ringe RP, Mukhopadhyay S, Patil A, Bichare S, Murugavel KG, Srikrishnan AK, Goyal R, Sok D, Bhattacharya J.
Retrovirology. 2021 May 14;18(1):12.

ICMR serosurveillance group. SARS-CoV-2 sero-prevalence among general population and healthcare workers in India, December 2020 - January 2021.

Murhekar MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, Kumar MS, Selvaraju S, Rade K, Girish Kumar CP, Sabarinathan R, Turuk A, Asthana S, Balachandar R, Bangar SD, Bansal AK, Chopra V, Das D, Deb AK, Devi KR, Dhikav V, Dwivedi GR, Muhammad Salim Khan S, Sunil Kumar M, Laxmaiah A, Madhukar M, Mahapatra A, Rangaraju C, Turuk J, Yadav R, Andhalkar R, Arunraj K, Bharadwaj DK, Bharti P, Bhattacharya D, Bhat J, Chahal AS, Chakraborty D, Chaudhury A, Deval H, Dhatrak S, Dayal R, Elantamilan D, Giridharan P, Haq I, Hudda RK, Jagjeevan B, Kalliath A, Kanungo S, Krishnan NN, Kshatri JS, Kumar A, Kumar N, Vinoth Kumar VG, Naga Lakshmi GGJ, Mehta G, Mishra NK, Mitra A, Nagbhushanam K, Nimmathota A, Nirmala AR, Pandey AK, Prasad GV, Qurieshi MA, Reddy SD, Robinson A, Sahay S, Saxena R, Sekar K, Shukla VK, Singh HB, Singh PK, Singh P, Singh R, Srinivasan N, Varma DS, Viramgami A, Wilson VC, Yadav S, Yadav S, Zaman K, Chakrabarti A, Das A, Dhaliwal RS, Dutta S, Kant R, Khan AM, Narain K, Narasimhaiah S, Padmapriyadarshini C, Pandey K, Pati S, Patil S, Rajkumar H, Ramarao T, Sharma YK, Singh S, Panda S, Reddy DCS, Bhargava B;
Int J Infect Dis. 2021 May 19;108:145–55.

Successful integration of HIV pre-exposure prophylaxis into a community-based HIV prevention program for female sex workers in Kolkata, India.

Jana S, Ray P, Roy S, Kadam A, Gangakhedkar RR, Rewari BB, Moses S, Becker ML
Int J STD AIDS. 2021 Jun; 32(7):638-647.

Layer-by-Layer Assembled Nanostructured Lipid Carriers for CD-44 Receptor-Based Targeting in HIV-Infected Macrophages for Efficient HIV-1 Inhibition.

Mahajan K, Rojekar S, Desai D, Kulkarni S, Bapat G, Zinjarde S, Vavia P.
AAPS PharmSciTech. 2021 Jun 7;22(5):171.

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2.

Sapkal GN, Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu KM, Abraham P, Panda S, Bhargava B.
J Travel Med. 2021 Jun 1;28(4):taab051.

Chlamydia Trachomatis Infection: Their potential implication in the Etiology of Cervical Cancer.

Yang X, Siddique A, Khan AA, Wang Q, Malik A, Jan AT, Rudayni HA, Chaudhary AA, Khan S.
J Cancer. 2021 Jun 11;12(16):4891-4900.

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai S, Panda S, Abraham P, Gupta N, Ella K, Bhargava B, Vadrevu KM.
Lancet Infect Dis. 2021 Jul;21(7):950-961.

India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis.

Mandal S, Arinaminpathy N, Bhargava B, Panda S.
BMJ Open. 2021 Jul 2;11(7):e048874.

District-level HIV estimates using the spectrum model in five states of India, 2017.

Kumar P, Sahu D, Rajan S, Mendu VVR, Das C, Kumar A, Chandra N, Camara B, Rai S, Arumugam E, Godbole SV, Singh SK, Kant S, Pandey A, Reddy DCS, Mehendale S
Medicine (Baltimore). 2021 Jul 16;100(28):e26578.

Ocular manifestations and refractive errors among people living with HIV in Pune, India: a cross-sectional study.

Ghate M, Gogate P, Phadke S, Shaikh G, Shidhaye P, Gurav S, Gadhe K, Bhusnawar M, Mane A, Panda S
J Int Med Res. 2021 Jul;49(7):3000605211026814

Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?

Khan AA
J Cancer Res Clin Oncol. 2021 Aug;147(8):2199-2207

Salmonella enterica subsp. enterica host-pathogen interactions and their implications in gallbladder cancer.

Khan AA, Bano Y.
Microb Pathog. 2021 Aug;157:105011.

Virological failure among HIV infected individuals on antiretroviral therapy in Pune, India: a cross-sectional study

Shidhaye P, Lokhande N, Kulkarni S, Gurav S, Deoraj P, Ghate M
Int J Adv Med. 2021 Aug; 8(8):1193-200.

Box-Behnken design aided optimization and validation of developed reverse phase HPLC analytical method for simultaneous quantification of dolutegravir sodium and lamivudine co-loaded in nano-liposomes.

Mutalik SP, Mullick P, Pandey A, Kulkarni SS, Mutalik S.
J Sep Sci. 2021 Aug; 44 (15): 2917-2931.

HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication.

Londhe R, Kulkarni S
Viruses. 2021 Aug;13(8): 1342

HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins.

Jadhav S, Nema V.
Mediators of Inflammation. 2021 Aug 25; 2021:1267041.

Both Full-Length and Protease-Cleaved Products of Osteopontin Are Elevated in Infectious Diseases.

Hattori T, Iwasaki-Hozumi H, Bai G, Chagan-Yasutan H, Shete A, Telan EF, Takahashi A, Ashino Y, Matsuba T.
Biomedicines. 2021 Aug 13;9(8):1006.

Multi-organ Targeting of HIV-1 Viral Reservoirs with Etravirine Loaded Nanostructured Lipid Carrier: An In-vivo Proof of Concept.

Rojekar S, Fotooh L, Pai R, Mahajan K, Kulkarni S, Vavia PR.
Eur J Pharm Sci. 2021 Sep 1;164:105916.

Responsive and agile vaccination strategies against COVID-19 in India.

Mandal S, Arinaminpathy N, Bhargava B, Panda S.
Lancet Glob Health. 2021 Sep; 9(9): e1197–e1200.

Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease.

Singh H, Singh A, Khan AA, Gupta V
Microb Pathog. 2021 Sep; 158: 105023.